Spruce BiosciencesSPRB
13F holders, Q1 2025 (March 31)31holders
5new positions
5sold out
1famous investor
$0.29avg. 13F price*
At the end of Q1 2025, 31 institutions reported holding Spruce Biosciences Inc. (SPRB) in their 13F filings, unchanged from Q4 2024. 5 opened new positions and 5 sold out. The largest holders were Carlyle Group Inc. ($840K), Rock Springs Capital Management LP ($757K) and Acadian Asset Management LLC ($301K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Spruce Biosciences Inc.
- CUSIP
- 85209E109
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $44K |
| Exits | 5 | $357K |
All 13F filers, Q4 2024 → Q1 2025: 197,220 shares bought and 925,338 shares sold, net −728,118 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 31 holders
| Carlyle Group Inc. | 0.02% | No change | 2,896,518 | $840K |
| Rock Springs Capital Management LP | 0.04% | No change | 2,609,125 | $757K |
| Acadian Asset Management LLC | 0.00% | No change | 1,045,828 | $301K |
| Ikarian Capital, LLC | 0.09% | No change | 1,000,000 | $290K |
| Vanguard Group Inc. | 0.00% | No change | 843,844 | $245K |
| ADAR1 Capital Management, LLC | 0.02% | No change | 403,716 | $117K |
| Renaissance Technologies | 0.00% | Reduce -5.7% | 382,900 | $111K |
| Boothbay Fund Management, LLC | 0.00% | No change | 288,800 | $84K |
| Geode Capital Management, LLC | 0.00% | Add +1.1% | 276,708 | $80K |
| BlackRock, Inc. | 0.00% | No change | 124,734 | $36K |
| UBS Group AG | 0.00% | Add +35.4% | 116,464 | $34K |
| Lion Point Capital, LP | 0.14% | No change | 75,000 | $22K |
| State Street Corp. | 0.00% | No change | 60,700 | $18K |
| Two Sigma Securities, LLC | 0.00% | New | 47,686 | $14K |
| XTX Topco Ltd | 0.00% | Add +15.9% | 41,217 | $12K |
| Shay Capital LLC | 0.00% | No change | 38,119 | $11K |
| Virtu Financial LLC | 0.00% | New | 39,426 | $11K |
| Jane Street Group, LLC | 0.00% | New | 37,429 | $11K |
| Northern Trust Corp. | 0.00% | Reduce -59.3% | 32,721 | $9K |
| Two Sigma Investments, LP | 0.00% | Reduce -0.3% | 20,545 | $6K |
| Ground Swell Capital, LLC | 0.01% | New | 17,312 | $5K |
| Marex Group Ltd | 0.00% | No change | 14,800 | $4K |
| Two Sigma Advisers, LP | 0.00% | Reduce -11.6% | 12,200 | $4K |
| Citigroup Inc. | 0.00% | New | 11,083 | $3K |
| Morgan Stanley | 0.00% | Add +246.7% | 7,396 | $2K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -1.3% | 4,697 | $1K |
| Group One Trading LLC | 0.00% | Reduce -34.8% | 1,153 | $334 |
| Caldwell Sutter Capital, Inc. | 0.00% | No change | 1,000 | $290 |
| Bank of America Corp. | 0.00% | Add +5.0% | 233 | $68 |
| BNP Paribas Financial Markets | 0.00% | No change | 181 | $52 |
| JPMorgan Chase & Co. | 0.00% | Reduce -5.8% | 65 | $19 |
"% of holder's portfolio" is SPRB's weight in each manager's 13F, not the share of Spruce Biosciences Inc. the manager owns.